http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5130145-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_464eb9068823683b5a4a63aa3cb13553
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1991-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ed15b055dc0c9193b6b3e1e8178ec1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adcda1e17aff5fd7c6775421076ac945
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d365dc815b5070cf8db7751c2a408ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c654144575684572ec3db0f930b93d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc7d5bf4f8fbbf482abce07200df5f73
publicationDate 1992-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5130145-A
titleOfInvention Pharmaceutical compositions with anit-cancer activity and method for the treatment of cancer
abstract Anti-cancer platinum complexes such as cisplatin exhibit a synergistically higher level of anti-tumour activity when administered substantially simultaneously either with L-ascorbic acid, or with 5,6-O-benzylidene-L-ascorbic acid or deuterated forms thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5955498-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6573050-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5846514-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004253180-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6306901-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7108845-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006275504-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003103896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6334997-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2289549-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5639787-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2266607-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6818200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5466678-A
priorityDate 1988-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0148094-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56605719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136230068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54682464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134359321

Total number of triples: 53.